Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma

M Gooptu, D Whitaker-Menezes, J Sprandio… - Seminars in …, 2017 - Elsevier
Metabolic heterogeneity between neoplastic cells and surrounding stroma has been
described in several epithelial malignancies; however, the metabolic phenotypes of …

Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma–MCT1 as potential target in diffuse large B cell lymphoma

J Afonso, T Pinto, S Simões-Sousa, F Schmitt… - Cellular oncology, 2019 - Springer
Purpose Increased glycolytic activity with accumulation of extracellular lactate is regarded as
a hallmark of cancer. In lymphomas, FDG-PET has undeniable diagnostic and prognostic …

Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment

L Mikkilineni, D Whitaker-Menezes… - Seminars in …, 2017 - Elsevier
Background Twenty percent of patients with classical Hodgkin Lymphoma (cHL) have
aggressive disease defined as relapsed or refractory disease to initial therapy. At present we …

[HTML][HTML] Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma

RA Noble, H Thomas, Y Zhao, L Herendi… - British Journal of …, 2022 - nature.com
Background We evaluated the therapeutic potential of combining the monocarboxylate
transporter 1 (MCT1) inhibitor AZD3965 with the mitochondrial respiratory Complex I …

Evidence for a stromal-epithelial “lactate shuttle” in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts

D Whitaker-Menezes, UE Martinez-Outschoorn, Z Lin… - Cell cycle, 2011 - Taylor & Francis
Recently, we proposed a new mechanism for understanding the Warburg effect in cancer
metabolism. In this new paradigm, cancer-associated fibroblasts undergo aerobic glycolysis …

[HTML][HTML] Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity

NJ Curtis, L Mooney, L Hopcroft, F Michopoulos… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Tumors frequently display a glycolytic phenotype with increased flux through glycolysis and
concomitant synthesis of lactate. To maintain glycolytic flux and prevent intracellular …

Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas

EN Bonglack, JE Messinger… - Proceedings of the …, 2021 - National Acad Sciences
Epstein–Barr virus (EBV) is a ubiquitous herpesvirus that typically causes asymptomatic
infection but can promote B lymphoid tumors in the immune suppressed. In vitro, EBV …

Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2–dependent glutaminolysis pathway

P Wei, AJ Bott, AA Cluntun, JT Morgan… - Science …, 2022 - science.org
The fate of pyruvate is a defining feature in many cell types. One major fate is mitochondrial
entry via the mitochondrial pyruvate carrier (MPC). We found that diffuse large B cell …

Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis

JR Doherty, C Yang, KEN Scott, MD Cameron… - Cancer research, 2014 - AACR
Myc oncoproteins induce genes driving aerobic glycolysis, including lactate dehydrogenase-
A that generates lactate. Here, we report that Myc controls transcription of the lactate …

[HTML][HTML] Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma

A Krug, R Mhaidly, M Tosolini, L Mondragon… - Cell Death …, 2024 - nature.com
Cancer metabolic reprogramming has been recognized as one of the cancer hallmarks that
promote cell proliferation, survival, as well as therapeutic resistance. Up-to-date regulation …